{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:15:47Z","timestamp":1715991347011},"reference-count":43,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"Roche Pharma"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.2217\/imt-2017-0182","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T11:08:14Z","timestamp":1520248094000},"page":"465-472","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Tocilizumab in the Treatment of Giant Cell Arteritis"],"prefix":"10.1080","volume":"10","author":[{"given":"Nicolai","family":"Leuchten","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine III, University Medical Center & Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Aringer","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine III, University Medical Center & Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24459"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-68566-3"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/md.0b013e31803d1764"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.5444"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11353"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160466"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140056"},{"issue":"2","key":"e_1_3_2_10_1","first-page":"S-19","article-title":"Noninfectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review","volume":"33","author":"Loricera J","year":"2015","unstructured":"Loricera J , BlancoR , HernandezJLet al. Noninfectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review . Clin. Exp. Rheumatol.33 ( 2 Suppl. 89 ), S-19 \u2013 S-31 ( 2015 ).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20231"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.08.009"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.7.481"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31825-1"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000180043.19285.54"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1214825"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22754"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2015.12.015"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq039a"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088351"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-200705010-00004"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.082115"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203586"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092163"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31821c4fad"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11388"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.146.2.550"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/29.6.456"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1411569"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22033"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068064"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1918"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq343"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209773"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.149351"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.04.2011.4135"},{"key":"e_1_3_2_37_1","first-page":"w13156","article-title":"Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series","volume":"141","author":"Seitz M","year":"2011","unstructured":"Seitz M , ReichenbachS , BonelHM , AdlerS , WermelingerF , VilligerPM . Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series . Swiss Med. Wkly141 , w13156 ( 2011 ).","journal-title":"Swiss Med. Wkly"},{"issue":"3","key":"e_1_3_2_38_1","first-page":"S79","article-title":"Tocilizumab in refractory aortitis: study on 16 patients and literature review","volume":"32","author":"Loricera J","year":"2014","unstructured":"Loricera J , BlancoR , CastanedaSet al. Tocilizumab in refractory aortitis: study on 16 patients and literature review . Clin. Exp. Rheumatol.32 ( 3 Suppl. 82 ), S79 \u2013 S89 ( 2014 ).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.12.005"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00560-2"},{"issue":"10","key":"e_1_3_2_41_1","article-title":"Termination of tocilizumab-treatment in giant cell arteritis: follow-up of patients after the RCT (ClinicalTrials.gov registration number: NCT01450137)","volume":"68","author":"Adler S","year":"2016","unstructured":"Adler S , ReichenbachS , KuchenSet al. Termination of tocilizumab-treatment in giant cell arteritis: follow-up of patients after the RCT (ClinicalTrials.gov registration number: NCT01450137) . Arthritis Rheum.68 ( Suppl. 10 ), Abstract 867 ( 2016 ).","journal-title":"Arthritis Rheum."},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613849"},{"issue":"15","key":"e_1_3_2_43_1","first-page":"1494","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone JH","year":"2017","unstructured":"Stone JH , KlearmanM , CollinsonN . Trial of tocilizumab in giant-cell arteritis . N. Engl. J. Med.377 ( 15 ), 1494 \u2013 1495 ( 2017 ).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"e_1_3_2_44_1","article-title":"Optimal dose of tocilizumab for the treatment of giant cell arteritis: efficacy, safety and exposure-efficacy analysis from GIACTA","volume":"76","author":"Stone JH","year":"2017","unstructured":"Stone JH , TuckwellK , DimonacoSet al. Optimal dose of tocilizumab for the treatment of giant cell arteritis: efficacy, safety and exposure-efficacy analysis from GIACTA . Ann. Rheum. Dis.76 ( Suppl. 2 ), Abstract OP0131 ( 2017 ).","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"e_1_3_2_45_1","article-title":"Tocilizumab monotherapy for polymyalgia rheumatica \u223c results of 52-week treatment of a prospective, single-center, open, single-arm trial","volume":"76","author":"Amano K","year":"2017","unstructured":"Amano K , ChinoK , OkadaYet al. Tocilizumab monotherapy for polymyalgia rheumatica \u223c results of 52-week treatment of a prospective, single-center, open, single-arm trial . EULAR Congress 201776 ( Suppl. 2 ), Abstract AB0984 ( 2017 ).","journal-title":"EULAR Congress 2017"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2017-0182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:01:24Z","timestamp":1715950884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2017-0182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.2217\/imt-2017-0182"],"URL":"https:\/\/doi.org\/10.2217\/imt-2017-0182","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}